About this trial
The goal of this clinical trial is to evaluate whether the topical application of Novox® Drop on surgical wounds after the extraction of lower third molars can have a clinical advantage.
The primary objective of the study is to evaluate the possible reduction of masseteric trismus (masticatory muscle spasm - primary outcome) and of post-operative pain and facial edema (swelling - secondary outcomes) after the extraction of impacted third molars compared to those who do not use it (placebo=glycerin-based gel).
Eligibility criteria
Qualifiers
good systemic and local health conditions of the patient;
age between 18 and 35 years;
understanding of the Italian language,
indications for the extraction of impacted bilateral lower third molars (38 and 48) according to the criteria reported in the classifications of Winter and that of Pell and Gregory;
Disqualifiers
diabetes mellitus;
systemic arterial hypertension;
hyperthyroidism;
osteoporosis;
Trial design
Treatments tested in this trial
- Hyper-oxygenated gel
- glycerin based gel